{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-016739","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2023-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.254297+00:00","generated_at":"2026-06-15T02:38:51.700489+00:00","sec_items":["3.02","5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Stockholders approve conversion of preferred shares; outstanding common to increase ~44% to 2.3M","bullets":["Special meeting on May 8, 2023: all four proposals passed, including conversion of Series C & D preferred into common.","Convertible notes with £1.36M outstanding balance to convert into 1,149,273 Series C shares, effective May 9.","Upon full conversion of Series C (3.5M shares) and Series D (176k shares), common outstanding will be ~2.29M (up from ~1.58M).","2019 Long Term Incentive Plan amended to increase authorized shares by 50,000 to 125,000 (Proposal 3 approved).","All conversions are in process and deemed effective as of May 10, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-016739","json":"https://secwatch.observer/filing/0001493152-23-016739.json","markdown":"https://secwatch.observer/filing/0001493152-23-016739.md","text":"https://secwatch.observer/filing/0001493152-23-016739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T02:38:51.700489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"41bb0c3c52c118db715523517f0da0e6872ab3a6","claim":"INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve the full conversion of Series C Convertible Preferred Stock and the issuance of shares of Common Stock in connection with such conversion.","evidence_excerpt":"FOR AGAINST ABSTAIN 530,145 7,392 71,927","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"475e22a7ce1a64fd6b6616505f1add9a52a78578","claim":"INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve an increase in the number of shares of Common Stock authorized for issuance under the 2019 Plan by 50,000 shares.","evidence_excerpt":"FOR AGAINST ABSTAIN 584,036 25,164 264","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"a96296c401df2dac38c99f17aeae1d3d35e269fb","claim":"INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve the full conversion of Series D Convertible Preferred Stock and the issuance of shares of Common Stock in connection with such conversion.","evidence_excerpt":"FOR AGAINST ABSTAIN 585,379 23,657 428","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"},{"claim_id":"ae9077b8fde4c6bfcee6c7947d4c0754a2bb93ce","claim":"INTELLIGENT BIO SOLUTIONS INC. shareholders approved To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies.","evidence_excerpt":"FOR AGAINST ABSTAIN 583,313 25,538 613","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315223016739/0001493152-23-016739-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}